Delivery Order SPE2DR25D2206-SPE2DR26F9MK4
Award Date 1/22/26
Potential Completion Date 1/23/26
Potential Value $3.7K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $2,784.00 to AmerisourceBergen Drug Corp for the supply of Tobramycin 1.2 GM vials, with a completion date of January 9, 2026. This is a firm fixed-price contract with no set-aside designation, meaning it was competitively awarded. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. This delivery order falls under the company's larger Indefinite Delivery Contract (IDC) with...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,645.00 by the Defense Logistics Agency (DLA) on August 22, 2025, for the supply of Tobramycin 1.2 GM vials, with an ultimate completion date of August 25, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $35,434.99 firm fixed-price delivery order is for the supply of Tobramycin 300 mg/4 ml ampules, a critical antibiotic medication. The contract has an ultimate completion date of May 15, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $1,219.89 contract is for the provision of Tobramycin 300 mg/5 ml ampules with a completion date of March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide Tobramycin 300 mg/5 ml ampules. The contract has a potential value of $4,188.53 and a completion date of January 31, 2024. Amerisourcebergen Drug Corp serves as a prime contractor for DLA Troop Support Medical, providing a range of pharmaceutical products and medical supplies to support military treatment programs. This...
- This is a $4,134.34 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Tobramycin 300 mg/5 ml ampule in 5 ml units. The order has an ultimate completion date of April 8, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to support military...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,513.70 Firm Fixed Price delivery order is for the supply of 4,566,264,597 units of Tobramycin 300 mg/4 ml Ampules. The award has an ultimate completion date of October 30, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $28,502.07 to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc. The order is for the supply of 4,564,261,702 units of the medication Tobramycin 300 mg/4 ml ampules. The delivery order has an ultimate completion date of April 15, 2024. Amerisourcebergen Drug Corp, as a prime contractor, also holds an indefinite delivery contract (IDC) with DLA worth up to $999,999,999.00 through...
- This federal contract award is for the delivery of Tobramycin 1.2 GM vials to the Defense Logistics Agency (DLA). The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on March 25, 2025, with a ceiling value of $1,888.72. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 26, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the delivery of Tobramycin 300 mg/5 ml ampules. The single-award contract has a firm fixed price of $1,007.78 and an ultimate completion date of January 12, 2022. Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., is a major supplier of pharmaceutical products and medical supplies to various government agencies,...